Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | CDC25B | P30305 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17337390 | 0.89 | TSHR (0.35) | TSHRL3MBTL1NPSR1CNR2CDC25B | |
| SCHEMBL17337392 | 0.89 | TSHR (0.35) | TSHRL3MBTL1NPSR1CNR2CDC25B | |
| SCHEMBL23837337 | 0.89 | AAK1 (0.33) | TSHRL3MBTL1NPSR1CNR2CDC25B | |
| SCHEMBL23837304 | 0.88 | TSHR (0.38) | TSHRL3MBTL1NPSR1CNR2CDC25B | |
| SCHEMBL23837326 | 0.87 | TSHR (0.33) | TSHRL3MBTL1NPSR1CNR2CDC25B | |
| SCHEMBL23837335 | 0.86 | CA1 (0.33) | TSHRL3MBTL1NPSR1CNR2CDC25B | |
| SCHEMBL23837341 | 0.86 | TSHR (0.32) | TSHRL3MBTL1NPSR1CNR2CDC25B | |
| SCHEMBL23837436 | 0.86 | TSHR (0.35) | TSHRL3MBTL1NPSR1CNR2CDC25B | |
| SCHEMBL17337325 | 0.83 | TSHR (0.36) | TSHRL3MBTL1NPSR1CNR2CDC25B | |
| SCHEMBL17337323 | 0.83 | TSHR (0.36) | TSHRL3MBTL1NPSR1CNR2CDC25B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3882252-A1 | BETA-LACTAMASE INHIBITORS | Venatorx Pharmaceuticals, Inc. (US) | 2021-09-22 | — | — | EP | disclosed |